Outsourcing Clinical Trials Europe
29 -30 April, 2025 // Barcelona, Spain
Join Worldwide Clinical Trials at Outsourcing Clinical Trials Europe.
13
days leftAbout event
Join pharma and biotech leaders as they collaborate to tackle industry challenges through innovation and strategic partnerships. If you’re attending Outsourcing Clinical Trials Europe, stop by booth #72 to connect with our team.
Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, will be presenting Beyond Boundaries – Unlocking the Potential of Cross-Border Enrollment in Clinical Trials on 29 April at 1 P.M CEST.
Clinical trials are the backbone of medical innovation, but one of the biggest challenges we face is patient recruitment. In an era where diseases know no borders, why should access to potentially life-saving treatments be limited by geography? Cross-border enrollment offers a powerful solution—expanding trial access, accelerating recruitment, and improving diversity. But it’s not without challenges. This session will
- Give a background on cross border enrollment and why it is a beneficial tool in clinical trial recruitment.
- Discuss some regulatory and logistical challenges when implementing cross border enrollment.
- Provide case studies of Worldwide Clinical Trials successful implementation of cross border enrollment strategies.
Date
Tuesday to Wednesday
29 – 30 April, 2025
Venue
Hyatt Regency Barcelona Tower
Avinguda de la Granvia de l’Hospitalet, 144
08907 Barcelona, Spain
Nathan Chadwick
Senior Director, Therapeutic Strategy Lead, Rare Disease
With more than a decade of dedicated experience in clinical research, Nathan Chadwick is well-versed in several therapeutic areas, with a specialized focus in neurology and rare disease. At Worldwide, Nathan is at the forefront of therapeutic strategy for rare disease, leading ongoing efforts with rare disease patient advocacy organizations while working to expand rare disease opportunities, studies, and initiatives.
